Country Selection for Clinical Research Trials

At SPRI, we base our country recommendations on a number of factors, including client preference, contractual requirements, regulatory timelines, patient population and patient enrollment timelines. Once we understand your specific needs, we’ll sit down as a team and decide which country can best meet your clinical research goals.

Key Selection Criteria

In formulating our country recommendations, SPRI’s feasibility team will evaluate several criteria and compare these criteria to your needs.

Our country selection criteria include:

  • Regulatory timelines & potential regulatory risks in the protocol design
  • Epidemiology
  • Standard of care
  • Competitive landscape
  • Potential obstacles (comparator availability, logistical issues, etc.)

After collecting and evaluating the above information, SPRI will provide you with our official recommendation. You’ll also have the opportunity to review the other options our team considered, allowing you to make the best choice for your research budget, timeline and internal commitments.

Put SPRI’s Expertise to Work For You

At SPRI, we have offices in the United States and Eastern Europe, as well as established partnerships in Australasia and Western Europe. Our clinical research experience and long-standing relationships provide us with the insight to help our clients choose the best country for their needs. Contact SPRI Clinical Trials today to learn about country selection services.